Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2025-02-18

FDA Approved: MESALAMINE — Original Application (Amneal Pharmaceuticals LLC)

View source ↗

Summary

FDA approved Amneal's original ANDA for Mesalamine, a generic mesalamine product. This approval authorizes marketing for ulcerative colitis, an inflammatory bow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mesalamine (Mesalamine)

Snippet

ORIG AP for MESALAMINE (MESALAMINE)